Astrocyte‐ TREM2 alleviates brain injury by regulating reactive astrocyte states following ischemic stroke
Glia · 2024-11 · 72 (11) · 2061-2078
DOI: 10.1002/glia.24597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, online erschienen am 26.07.2024. Verfasst von Cong Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of…. Hauptthemen laut MEDLINE: Receptors, Immunologic, Astrocytes, Ischemic Stroke, Membrane Glycoproteins. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Triggering receptor expressed on myeloid cells 2 (TREM2) has been shown to confer strong neuroprotective effects in acute ischemic stroke (AIS). However, as the vast majority of research findings to date are based on its functions in microglia, the precise role of TREM2 in astrocytes after AIS is unknown. Here, both loss‐ and gain‐of‐function experiments were employed to investigate how astrocytic TREM2 influences the pathogenesis of AIS in vivo and in vitro. Our results demonstrated that cerebral ischemia triggered induction of TREM2 expression on reactive astrocytes following AIS. In addition, astrocyte‐specific TREM2 knockout mice exhibited much greater brain injury than TREM2 flox/flox controls following AIS, as evidenced by increased cerebral infarct volume, neuronal apoptosis and neurological deficit, which was associated with an increased expression of pro‐inflammatory molecule complement component 3 (C3) on reactive astrocytes and activation of microglia/macrophages but decreased expression of S100 calcium binding protein A10 (S100A10) and arginase1 (Arg1) on reactive astrocytes. Mechanistic analyses revealed that astrocytic TREM2 alleviated brain injury by inhibiting detrimental actions of reactive astrocytes but promoting their neuro‐ and glioprotective actions via the kruppel‐like transcription factor‐4‐nuclear factor‐κB axis. Together, this study provides novel evidence for a critical protective role of astrocyte‐derived TREM2 in AIS and highlights a potential therapeutic target for the treatment of AIS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
- The Graduate School, Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China.
- Department of Pharmacy, Gongli Hospital, Pudong New Area, Shanghai, Shanghai, People's Republic of China.
- Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
- Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
- San Diego Biomedical Research Institute, San Diego, California, USA.
ORCID-Profile: Richard Milner, Longxuan Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, C., Dong, J., Huang, H., Zhou, K., Liu, Z., Milner, R., & Li, L. (2024). Astrocyte‐ TREM2 alleviates brain injury by regulating reactive astrocyte states following ischemic stroke. Glia, 72(11), 2061-2078. https://doi.org/10.1002/glia.24597
Vancouver
Wang C, Dong J, Huang H, Zhou K, Liu Z, Milner R, et al. Astrocyte‐ TREM2 alleviates brain injury by regulating reactive astrocyte states following ischemic stroke. Glia. 2024;72(11):2061-2078. doi:10.1002/glia.24597
BibTeX
@article{Wang2024,
author = {Wang, Cong and Dong, Jing and Huang, Heng and Zhou, Kegui and Liu, Zhenguo and Milner, Richard and Li, Longxuan},
title = {Astrocyte‐ TREM2 alleviates brain injury by regulating reactive astrocyte states following ischemic stroke},
journal = {Glia},
year = {2024},
volume = {72},
number = {11},
pages = {2061--2078},
doi = {10.1002/glia.24597}
}
EUVIMED